Terms: = Sarcomas AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10 AND Treatment
5 results:
1. Mechanism of lysine oxidase-like 1 promoting synovial inflammation mediating rheumatoid arthritis development.
Hu J; Liu X; Xu Q; Zhu M; Wang S; Quan K; Dai M; Mo F; Zhan H
Aging (Albany NY); 2024 Jan; 16(1):928-947. PubMed ID: 38217541
[TBL] [Abstract] [Full Text] [Related]
2. PIK3CA somatic mutation in sinonasal teratocarcinosarcoma.
Belardinilli F; De Vincentiis L; D'Ecclesia A; Giannini G; Giangaspero F; Corsi A
Auris Nasus Larynx; 2021 Jun; 48(3):530-534. PubMed ID: 32389511
[TBL] [Abstract] [Full Text] [Related]
3. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
[TBL] [Abstract] [Full Text] [Related]
4. An Epithelial-to-Mesenchymal Transcriptional Switch Triggers Evolution of Pulmonary Sarcomatoid Carcinoma (PSC) and Identifies Dasatinib as New Therapeutic Option.
Manzotti G; Torricelli F; Benedetta D; Lococo F; Sancisi V; Rossi G; Piana S; Ciarrocchi A
Clin Cancer Res; 2019 Apr; 25(7):2348-2360. PubMed ID: 30587547
[TBL] [Abstract] [Full Text] [Related]
5. Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and ddr2 rearrangements.
Egan JB; Barrett MT; Champion MD; Middha S; Lenkiewicz E; Evers L; Francis P; Schmidt J; Shi CX; Van Wier S; Badar S; Ahmann G; Kortuem KM; Boczek NJ; Fonseca R; Craig DW; Carpten JD; Borad MJ; Stewart AK
PLoS One; 2014; 9(2):e87113. PubMed ID: 24505276
[TBL] [Abstract] [Full Text] [Related]
